by Marijn van Jaarsveld | Jun 30, 2023 | Uncategorized
MPE’s video interviews with CARAMBA researchers Myeloma Patients Europe conducted a series of interviews with CARAMBA researchers on the challenges of CAR T-cell therapy. Watch the videos below, produced by Myeloma Patients Europe. CARAMBA clinical trial...
by Marijn van Jaarsveld | Jun 30, 2023 | Uncategorized
The CARAMBA project presents its experiences, lessons learned and achievements in the development of an innovative CAR T-cell therapy for Multiple Myeloma treatment Read more in this meeting report.
by Marijn van Jaarsveld | Jun 30, 2023 | Uncategorized
On 30th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and beyond. The ultimate goal of the CARAMBA project was to develop a new virus-free CAR-T...
by Sandra Annetzberger | Jun 13, 2023 | Uncategorized
On 8th June 2023, the CARAMBA consortium held its 6th and final General Assembly meeting in Frankfurt. Coordinator Prof. Dr. Michael Hudecek provided an overview on the project objectives, success stories, challenges, and future perspectives. The CARAMBA partners...
by Sabine Possmann | Dec 16, 2022 | Uncategorized
On 15th December, the SME T-CURX GmbH announced the appointment of Thomas Loeser as the new CFO of the company and the attendance of the JPM 41st Annual Healthcare Conference 2023 in San Francisco from Jan 9-12, 2023.Tom has served for more than 20 years as CFO of...
by Sabine Possmann | Dec 8, 2022 | Uncategorized
Monica Casucci, group leader of the innovative immunotherapies unit at IRCCS Ospedale San Raffaele, was awarded by the European Research Council, to refine her outstanding research work on a novel CAR specific for the CD44v6 antigen and strategies to improve CAR-T...